Immix Biopharma, Inc. Grants Receivable
Financial Statements › Balance Sheet › Assets
us-gaap:GrantsReceivable · last filed 2026-08-07
- 2026-06-30: Grants Receivable $6.70M.
- 2026-03-31: Grants Receivable $6.20M.
- 2025-12-31: Grants Receivable $4.60M.
- 2025-09-30: Grants Receivable $4.60M.
| Period end | Grants Receivable |
|---|---|
| 2026-06-30 | $6.70M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $6.20M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $4.60M 10-K/A · filed 2026-03-27 |
| 2025-09-30 | $4.60M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $3.60M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $1.70M 10-Q · filed 2025-08-08 |
| 2024-07-25 | $8.00M 10-Q · filed 2026-08-07 |